1. Home
  2. WVE vs NHC Comparison

WVE vs NHC Comparison

Compare WVE & NHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$12.65

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo National HealthCare Corporation

NHC

National HealthCare Corporation

HOLD

Current Price

$171.15

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
NHC
Founded
2012
1971
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.3B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
WVE
NHC
Price
$12.65
$171.15
Analyst Decision
Strong Buy
Analyst Count
16
0
Target Price
$30.44
N/A
AVG Volume (30 Days)
3.2M
60.8K
Earning Date
03-03-2026
02-13-2026
Dividend Yield
N/A
1.51%
EPS Growth
N/A
N/A
EPS
N/A
6.48
Revenue
$109,230,000.00
$1,500,618,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$16.10
N/A
P/E Ratio
N/A
$26.17
Revenue Growth
103.75
22.67
52 Week Low
$5.28
$89.14
52 Week High
$21.73
$171.64

Technical Indicators

Market Signals
Indicator
WVE
NHC
Relative Strength Index (RSI) 41.05 81.03
Support Level $12.51 $158.28
Resistance Level $14.15 $171.64
Average True Range (ATR) 0.76 4.91
MACD -0.04 2.15
Stochastic Oscillator 8.29 94.18

Price Performance

Historical Comparison
WVE
NHC

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About NHC National HealthCare Corporation

National Healthcare Corp Provides long-term care facilities. Its principal business includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services, and Home care hospice services. Generating, a majority of its revenue from Inpatient services.

Share on Social Networks: